Illumina, Investment Firms Form Consumer Genomics Company | GenomeWeb

NEW YORK (GenomeWeb) – Illumina and private equity firms Warburg Pincus and Sutter Hill Ventures announced today that they have formed a consumer genomics firm called Helix, which has received financing commitments of more than $100 million.

According to the partners, they founded Helix to provide affordable sequencing and database services for consumer samples obtained through third-party partners. Customers will be able to manage their data and have access to a marketplace of on-demand applications provided by Helix partners in order to gain insights into the genomic data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.